Last deal

$2.9M

Amount

Series B

Stage

24.12.2015

Date

2

all rounds

$39.9M

Total amount

General

About Company
Panacela Labs is a clinical-stage biotechnology company focusing on oncology and orphan drug development.

Industry

Sector :

Subsector :

Also Known As

PANACELA LABS INC.

founded date

01.01.2011

Number of employees

Company Type

For Profit

Last funding type

Series B

IPO status

Private

Description

Panacela Labs is a clinical-stage biotechnology company that develops gene therapy drugs for cancer and infectious diseases.